Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME

Assistance Publique - Hôpitaux de Paris

Status: Completed

Conditions: Drug Dependence

Treatments: Behavioral: self-questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT04709016

2020-A02182-37

Details and patient eligibility

About

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

Enrollment: 100 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age> 18
• male or transgender
• MSM or bi-sexual orientation
• adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)
• adult with a Smartphone (online self-questionnaire)

Exclusion criteria

• For the group "taking PrEP": adult taking PrEP for less than 3 months
• Refusal of participation

Trial design

100 participants in 1 patient group

male or transgender patients

Description:

of sexual orientation MSM (men having sex with men) or bi-sexual, consultant in sexual health centers

Treatment:

Behavioral: self-questionnaire